The Actinic Keratosis Market is expected to increase at a CAGR of 5.70 percent, from USD 4,207.68 million in 2020 to USD 6,704.45 million in 2026.
The actinic keratosis market is predicted to grow due to the rising complications connected with the disease.
Actinic keratosis is being treated as part of a preventive effort to reduce associated conditions such non-melanoma skin cancer, squamous cell carcinoma, and basal cell carcinoma. Actinic keratosis is thought to be the cause of over 60% of squamous cell carcinomas in the skin, according to the US National Library of Medicine in 2015. As a result, rising skin cancer rates, such as intra epidermal squamous cell carcinoma, invasive cutaneous squamous cell carcinoma, basal cell carcinoma, and melanoma, are predicted to boost market growth.
Read more @ https://cmilatestinsights.blogspot.com/2022/01/actinic-keratosis-treatment-market.html
